19-38305412-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001039672.3(YIF1B):c.885G>A(p.Met295Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,610,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M295V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001039672.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
YIF1B | NM_001039672.3 | c.885G>A | p.Met295Ile | missense_variant | 8/8 | ENST00000339413.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
YIF1B | ENST00000339413.11 | c.885G>A | p.Met295Ile | missense_variant | 8/8 | 1 | NM_001039672.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245116Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134006
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1458308Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 725038
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152360Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74510
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2021 | The c.885G>A (p.M295I) alteration is located in exon 8 (coding exon 8) of the YIF1B gene. This alteration results from a G to A substitution at nucleotide position 885, causing the methionine (M) at amino acid position 295 to be replaced by an isoleucine (I). The p.M295I alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at